ARTICLE | Clinical News
TXA127 regulatory update
January 27, 2017 9:09 PM UTC
FDA granted rare pediatric disease designation to TXA127 from Tarix to treat recessive dystrophic epidermolysis bullosa (RDEB). TXA127, a formulation of the angiotensin (1-7) peptide, a MAS receptor a...
BCIQ Company Profiles
BCIQ Target Profiles